Stock BIOX BIOCERES CROP SOLUTIONS CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Bioceres Crop Solutions Corp.

Equities

BIOX

KYG1117K1141

Real-time Estimate Cboe BZX
Other stock markets
 02:07:16 2024-06-10 pm EDT 		5-day change 1st Jan Change
10.78 USD +0.94% Intraday chart for Bioceres Crop Solutions Corp. -5.04% -21.85%
May. 14 Transcript : Bioceres Crop Solutions Corp., Q3 2024 Earnings Call, May 14, 2024
May. 14 Bioceres Crop Solutions Fiscal Q3 Earnings, Revenue Fall MT

Summary

  • Overall, the company has poor fundamentals for a medium to long-term investment strategy.
  • From a short-term investment perspective, the company presents a deteriorated fundamental situation

Strengths

  • Growth is a substantial asset for the company, as anticipated by dedicated analysts. Within the next three years, growth is estimated to reach 67% by 2026.
  • The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
  • Analyst opinion has improved significantly over the past four months.
  • Over the past twelve months, analysts' opinions have been strongly revised upwards.

Weaknesses

  • With a 2024 P/E ratio at 33.38 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
  • The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
  • For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
  • The company's earnings releases usually do not meet expectations.

Ratings chart - Surperformance

Sector: Agricultural Chemicals

1st Jan change Capi. Investor Rating ESG Refinitiv
BIOCERES CROP SOLUTIONS CORP. Stock Bioceres Crop Solutions Corp.
-22.21% 671M -
CORTEVA, INC. Stock Corteva, Inc.
+10.39% 36.87B
C
PHOSAGRO Stock PhosAgro
-.--% 11.53B -
B+
FMC CORPORATION Stock FMC Corporation
-10.13% 7.07B
A
PI INDUSTRIES LIMITED Stock PI Industries Limited
+2.70% 6.61B
B-
ICL GROUP LTD Stock ICL Group Ltd
-5.01% 5.92B
B+
OCI N.V. Stock OCI N.V.
-5.49% 5.65B
B
THE FERTILISERS AND CHEMICALS TRAVANCORE LIMITED Stock The Fertilisers and Chemicals Travancore Limited
-6.01% 5.42B -
C-
YUNNAN YUNTIANHUA CO., LTD. Stock Yunnan Yuntianhua Co., Ltd.
+36.15% 5.38B
B-
UPL LIMITED Stock UPL Limited
-8.20% 4.85B
C+
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
-

Valuation

P/E ratio
EV / Sales
-
Price to Book
Price to Free Cash Flow
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. BIOX Stock
  4. Ratings Bioceres Crop Solutions Corp.